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C
DObjectives: Techniques employed today concomitantly with left-sided heart valve surgery address secondary
tricuspid valve regurgitation at 3 anatomic levels—annulus, commissure, and leaflet—although success of these
alone or in combination in eliminating tricuspid regurgitation is uncertain. Our objective was to assess the com-
parative effectiveness of these techniques in reducing or eliminating secondary tricuspid regurgitation.
Methods: From 1990 to 2008, 2277 patients underwent tricuspid valve procedures for secondary tricuspid regur-
gitation concomitantly with mitral (n ¼ 1527, 67%), aortic (n ¼ 180, 7.9%), or combined (n ¼ 570, 25%) valve
surgery. These included annulus (flexible prosthesis [n ¼ 1052, 46%], rigid prosthesis [standard ¼ 387,
3-dimensional ¼ 197; 26%], Peri-Guard annuloplasty [Synovis Surgical Innovations, St Paul, Minn; n ¼ 185,
8.1%], and De Vega suture [n ¼ 129, 5.7%]), commissure (Kay [n ¼ 248, 11%]), and leaflet (edge-to-edge
suture [n ¼ 79, 3.5%]  annulus or commissural) procedures. A total of 4745 postoperative transthoracic echo-
cardiograms in 1965 patients were analyzed.
Results: By 3 months after surgery, only 32% of patients overall had no tricuspid regurgitation. However, by 5
years, this had decreased to 22%, and 3þ/4þtricuspid regurgitation had increased from 11% at 3 months to 17%.
Patients with rigid ring annuloplasty alone, either standard or 3-dimensional, had the least increase of 3þ/4þ
tricuspid regurgitation (to 12% at 5 years) compared with either a commissural or leaflet procedure.
Conclusion: Rigid prosthetic ring annuloplasty, standard or 3-dimensional, provides early and sustained reduc-
tion of tricuspid regurgitation secondary to left-sided valve disease without need for an additional leaflet proce-
dure. However, results are imperfect, possibly because other anatomic levels (subvalvular, papillary muscle,
and right ventricular) contributing to its pathophysiology are unaddressed. (J Thorac Cardiovasc Surg
2010;139:1473-82)Supplemental material is available online.Secondary tricuspid valve regurgitation (TR) is frequent in
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The Journal of Thoracic and Caratrial fibrillation.1 Uncorrected, moderate, or severe TR is
associated with progressive heart failure and premature
death2; even if corrected, it is a marker of lower long-
term survival. However, the optimal surgical technique to
eliminate TR remains challenging.3 Techniques employed
today concomitantly with left-sided heart valve surgery ad-
dress TR at 3 anatomic levels—annulus, commissure, and
leaflet—although the degree to which these alone or in
combination are successful in sustained elimination of
TR is uncertain. Therefore, the objective of this study
was to assess comparative effectiveness of techniques ad-
dressing these anatomic levels in reducing or eliminating
secondary TR.
PATIENTS AND METHODS
Patients
From January 1990 to January 2008, 2277 patients underwent left-sided
valve surgery with a concomitant tricuspid valve repair (Table 1). The ma-
jority of patients underwent mitral valve procedures, and the predominant
etiology was degenerative disease with regurgitation. Nearly half had previ-
ously undergone cardiac surgery.
Data were retrieved from the prospective Cardiovascular Information
Registry (CVIR) and Echocardiography Database, both of which are ap-
proved for use in research by the institutional review board, with patient
consent waived.diovascular Surgery c Volume 139, Number 6 1473
TABLE 1. Patient characteristics, comorbidity, and procedure
variables (n ¼ 2277)
Variable n*
No. (%) or
mean ± SD
Demography
Female 2277 1376 (60)
Age (y) 2277 68  12
NYHA functional class 2277
I 181 (7.9)
II 963 (42)
III 894 (39)
IV 239 (10)
Valve pathophysiology
TR grade 2214
0 49 (2.2)
1þ 49 (2.2)
2þ 286 (13)
3þ 989 (45)
4þ 841 (38)
Pulmonary valve regurgitation grade 2121
0 113 (5.3)
1þ 98 (4.6)
2þ 339 (16)
3þ 911 (43)
4þ 660 (31)
Valve hemodynamics
Mitral 2062
None 130 (6.0)
Pure stenosisy 102 (5.0)
Pure regurgitationz 1,561 (76)
Mixed stenosis/regurgitationx 269 (13)
Aortic 1963
None 1153 (59)
Pure stenosisy 203 (10)
Pure regurgitationz 373 (19)
Mixed stenosis/regurgitationx 234 (12)
Valve etiology
Mitral 2277
None (n/a) 114 (5.0)
Degenerative 737 (32)
Rheumatic 471 (21)
Ischemic 344 (15)
Endocarditis 51 (22)
Other 560 (25)
Aortic 2277
None (n/a) 951 (42)
Degenerative 550 (24)
Rheumatic 165 (7.2)
Endocarditis 39 (1.7)
Other 572 (25)
Cardiac comorbidity
Previous myocardial infarction 2277 714 (31)
Ejection fraction (%) 2205 47þ14
LV dysfunction grade 2229
None 1,425 (64)
Mild 210 (9.4)
Moderate 246 (11)
Abbreviations and Acronyms
LV ¼ left ventricular
NYHA ¼ New York Heart Association
RV ¼ right ventricular
TR ¼ tricuspid valve regurgitation
TTE ¼ transthoracic echocardiography
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DAnatomic Level of Repair and Procedure Groups
We categorize repair procedures by anatomic level: annulus (flexible and
standard or 3-dimensional rigid prosthetic rings, Peri-Guard rings [Synovis
Surgical Innovations, St Paul, Minn], and De Vega suture technique), com-
missure (Kay technique), and leaflet (edge-to-edge technique). These were
performed at a single level or double levels (Table 2). From these combina-
tions, we formed 8 groups for analysis: 6 isolated to 1 level (annular: flexible
ring [standard and 3-dimensional], rigid ring, Peri-Guard ring, and De Vega
technique4; commissural: Kay technique5) and 2 involving 2 levels (edge-
to-edge plus prosthetic annuloplasty,6,7 edge-to-edge plus Kay technique);
6 patients with isolated edge-to-edge technique were not considered.
During the study period, number and variety of tricuspid valve repair
procedures fluctuated (Figure 1). Early in the series, procedures were per-
formed almost entirely at the annular level only, predominantly standard
rigid prosthetic ring and Peri-Guard annuloplasty. Later, flexible prosthetic
rings were introduced along with Kay commissuroplasty. In recent years,
rigid rings, both standard and 3-dimensional, have increasingly displaced
flexible rings, and edge-to-edge technique has been combined with both an-
nular and commissural level procedures.
Assessment of Postoperative TR
Temporal trend of TR grades after the repair was assessed by transtho-
racic echocardiography (TTE). TTE was performed routinely before dis-
charge and at the discretion of referring physicians during follow-up.
Interpretation of follow-up echocardiograms was obtained at as many time
points as available for each patient. A total of 4745 TTE records were avail-
able in 1965 patients (86% of the total population) with a median follow-up
of 20 days (25th percentile 6 days, 75th percentile 1.4 years, range 1 day to 18
years) (Appendix E1). TR was graded 0 for no regurgitation, 1þfor mild, 2þ
for moderate, 3þ for moderately severe, and 4þ for severe. Because of low
frequency in grades 3þand 4þ, they were combined into 1 category, 3þ/4þ.
Temporal pattern of postoperative TR grade was estimated longitudi-
nally using a nonlinear cumulative mixed model. With this model, a number
of temporal phases were identified and estimates obtained for the shaping
parameters of each phase. The SAS procedure PROC NLMIXED for longi-
tudinal nonlinear cumulative logistic regression8 for repeated measurements
was used for this (SAS Institute, Inc, Cary, NC). Because temporal patterns
of TR differed for each repair technique, we analyzed these individually.
Risk factors for postoperative TR. Because of the limited capa-
bility of PROC NLMIXED to explore multivariable relations, we initially
screened the variables listed in Appendix 1 using ordinary multivariable lo-
gistic regression (PROC LOGISTIC; SAS, Inc) and the assumption of inde-
pendence of observations, with liberal entry (P ¼ .2) and stay (P ¼ .12)
criteria. This analysis was performed simply to identify possible candidates
for the repeated-measurements multivariable model. These candidates and
their transformations, if any, were entered at once into the model, then elim-
inated one by one until all variables remaining had a P value of 0.1 or less.
Other Outcomes
Methods of analysis according to surgical management of TR; long-term
tricuspid valve reoperation, survival, and requirement for permanent pace-
maker; and estimated right ventricular (RV) systolic pressure and New1474 The Journal of Thoracic and Cardiovascular Surgery c June 2010
TABLE 1. Continued
Variable n*
No. (%) or
mean ± SD
Severe 348 (16)
Atrial fibrillation/flutter 2277 1,549 (68)
Complete heart block/pacer 2277 335 (15)
Ventricular arrhythmia 2277 428 (19)
Previous cardiac operation 2277 1,089 (48)
Noncardiac comorbidity
PAD 2275 1,001 (44)
Stroke 2277 295 (13)
Hypertension 2224 1,432 (64)
COPD 1984 636 (32)
Treated diabetes 2256 444 (20)
Creatinine (mg $ dL1) 2225 1.3  0.94
BUN (mg $ dL1) 2233 27  15
Left-sided valve procedure 2277
Mitral valve alone 1,527 (67)
Aortic valve alone 180 (7.9)
Aorticþmitral valve 570 (25)
Concomitant procedure
CABG 775 (34)
Atrial fibrillation ablation 513 (23)
SD, Standard deviation; NYHA, New York Heart Association; TR, Tricuspid valve re-
gurgitation; n/a, not available; LV, left ventricular; PAD, peripheral arterial disease;
COPD, chronic obstructive pulmonary disease; BUN, blood urea nitrogen; CABG,
coronary artery bypass grafting. *Number of patients with data available. yStenosis
greater than mild and regurgitation none or mild. zRegurgitation greater than mild
and stenosis none or mild. xStenosis and regurgitation greater than mild.
TABLE 2. Anatomic repair levels
Level No. (%)
One level
Annulus
Flexible prosthesis* 1052 (46)
Rigid prosthesisy 584 (26)
Peri-Guard 185 (8.1)
De Vega technique 129 (5.7)
Commissure
Kay technique 248 (11)
Leaflet
Edge-to-edge technique 6 (0.3)
Total 2204 (97)
Two levels
Leafletþannulus
Edge-to-edgeþflexible prosthesis 23 (1.0)
Edge-to-edgeþ rigid prosthesis 12 (0.53)
Leafletþcommissure
Edge-to-edgeþKay technique 38 (1.7)
Total 73 (3.2)
*Cosgrove–Edwards band (n ¼ 1049); St Jude Medical Tailor annuloplasty band
(n ¼ 3). yStandard (Carpentier–Edwards ring [(n ¼ 387]) or 3-dimensional (Edwards
MC3 [n ¼ 196], IMR ETlogix [n¼1]).
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sented in Appendix E2.
Presentation
Simple descriptive statistics were used to summarize the data. Continu-
ous variables are presented as mean  standard deviation and as 15th, 50th
(median), and 85th percentiles. Categorical data are described using fre-
quencies and percentages. Categorical outcomes were compared using ei-
ther c2 or Fisher’s exact test and continuous outcomes by the Wilcoxon
rank–sum (Kruskal–Wallis) nonparametric test. All analyses were per-
formed using SAS statistical software (SAS version 9.1; SAS, Inc). Uncer-
tainty is expressed by confidence limits equivalent to 1 standard error
(68%).RESULTS
Postoperative TR, Overall
By 3 months after surgery, only 32% of patients had no
TR, 34% had mild (1þ) TR, 23% had moderate (2þ) TR,
and 11% had moderately severe to severe (3þ/4þ) TR
(Figure 2). Thereafter, prevalence of 2þ and greater TR
slowly increased and 0 TR decreased, such that by 5 years,
22% of patients had no TR, 33% had mild TR, 28% had
moderate TR, and 17% 3þ/4þTR.Postoperative TR by Anatomic Procedure Level
The temporal pattern of 3þ/4þ postoperative TR varied
considerably among the 8 procedure groups (Figure 3).The Journal of Thoracic and CarIsolated procedures at the annular level, with the exception
of Peri-Guard, had similar patterns of postoperative TR,
with an early rapid increase followed by a slower later in-
crease. Of these, patients with either standard or 3-dimen-
sional rigid prosthetic ring annuloplasty had the least
increase across time, to 10% and 14% by 5 years, respec-
tively (P¼ .7), compared with 16% for those receiving flex-
ible prosthetic rings and 24% for those with De Vega
annuloplasty. The isolated commissure-level Kay technique
was associated with a temporal pattern of TR similar to that
of flexible rings, reaching 19% 3þ/4þ by 5 years. Data for
2-level procedures involving a leaflet-level procedure
(edge-to-edge technique) are limited to 2 years because of
their recent introduction, but to date follow different patterns
of TR return. When an edge-to-edge procedure was com-
bined with a Kay procedure, initial prevalence of 3þ/4þTR
was low (2.4% at 3 months) but then rose to 24% by 2 years.
In contrast, the pattern of 3þ/4þTR prevalence after an edge-
to-edge technique combined with either rigid or flexible
prosthetic annuloplasty followed that of an isolated rigid
prosthetic ring, with a prevalence of 8% at 3 months and
8.8% at 2 years.Risk Factors for Postoperative TR
In addition to surgical management strategies for TR,
other factors increasing the risk of recurrent TR included
higher grade of preoperative TR, larger tricuspid annulo-
plasty ring size (larger tricuspid valve), presence of pace-
maker leads through the tricuspid valve, mitral valve
replacement rather than repair, poor left ventricular (LV)
function, and increased LV remodeling (Table 3).diovascular Surgery c Volume 139, Number 6 1475
FIGURE 1. Tricuspid valve procedures across time. C-E, Carpentier–Edwards rigid ring; MC3, Edwards MC3 Annuloplasty System 3-dimensional ring.
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Differences observed among the 7 repair groups with
respect to postoperative morbidity and mortality did not dem-
onstrate a consistent pattern (Appendix E3). Twenty-nine pa-
tients underwent a tricuspid valve reoperation, with freedom
from reoperation of 98% at 5 years overall (Appendix E4).
Risk of reoperation was similar among procedure groups
(P> .5; Figure 4). Overall survival was 83%, 64%, and
44% at 1, 5, and 10 years, respectively (Appendix E5). In un-
adjusted comparison, De Vega, Peri-Guard, and annulus plusFIGURE 2. Overall temporal trend of postoperative tricuspid regurgitation (TR)
of percentage of patients (mean effect) in each TR grade. Symbols represent data
vide a crude verification of model fit.
1476 The Journal of Thoracic and Cardiovascular Surleaflet repair groups appeared (P[log–rank] ¼ .05) to have
lower survival than patients receiving flexible and rigid annu-
loplasty rings alone (Figure 5).
Permanent pacemakers were present in 363 patients be-
fore operation, and 203 additional patients received a pace-
maker during follow-up. Freedom from postoperative
pacemaker insertion was 90%, 89%, and 87% at 30 days,
1 year, and 5 years, respectively. Patients with an annulus
plus leaflet procedure tended (P¼ .07) to have greater pace-
maker requirement (Appendix E6), and 18 of 20 withoutgrades after tricuspid valve repair. Solid lines represent parametric estimates
grouped without regard to repeated measurements within time frame to pro-
gery c June 2010
FIGURE 3. Prevalence of postoperative tricuspid regurgitation (TR) 3þ/4þfor each procedure group. The parametric estimates are based on separate decom-
position models for each procedure group. Solid lines represent unadjusted estimates of TR grades 3þor 4þfor each procedure group. Symbols represent data
grouped without regard to repeated measurements within a time frame to provide a crude verification of model fit. C-E, Carpentier–Edwards rigid ring; MC3,
Edwards MC3 Anuloplasty System 3-dimensional ring.
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valve procedure had a surgical approach to the mitral valve
through the atrial septum (90%).
Estimated RV systolic pressure changed minimally after
operation. Leaflet procedures appeared to have slightly
higher pressure than annuloplasty rings alone or a De
Vega annuloplasty (Appendix E7).
Among the one third of patients with longitudinal assess-
ment of NYHA functional class, those receiving a Peri-
Guard annuloplasty alone appeared to have better functional
status (P ¼.0002; Appendix E8).
DISCUSSION
Principal Findings
Regardless of anatomic level of procedure—annulus,
commissure, or leaflet, alone or in combination—we ob-
served early return of TR, and severe TR progressively in-
creased over time. However, the temporal pattern and
degree of return of TR varied with procedure. A standard
or 3-dimensional rigid prosthetic annuloplasty alone pro-
vided the best early and sustained reduction of TR, without
need for a procedure at a second level. The disappointing
finding that secondary TR is not permanently eliminated
by these procedures is consistent with observations of
others.9,10
Historical Note
For many years it was believed that secondary TR disap-
peared after mitral valve surgery alone,11 and consequently,
it was ignored.12 Thus, for example, Braunwald, Ross, and
Morrow11 in 1967 recommended conservative nonsurgical
management of ‘‘functional’’ TR. In the 1980s it was ob-The Journal of Thoracic and Carserved that patients who had undergone successful mitral
surgery sometimes returned years later with severe symp-
tomatic TR. When these patients underwent reoperation,
mortality was high.13 More recently, compelling data have
shown that surgically untreated secondary TR can persist
or even worsen despite correction of the associated left-
sided lesion,14 suggesting that an aggressive approach to-
ward secondary TR is warranted.10,14,15
Pathogenesis of Secondary TR
Secondary TR associated with left-sided valve disease is
thought to be caused by RV dilatation,16-18 with
enlargement and distortion of the tricuspid annulus and
tethering of the tricuspid leaflets. This causes rising left
atrial pressure that is transmitted through the lungs as
pulmonary arterial hypertension, resulting in pressure
overload on the RV. TR itself leads to further RV dilation
and dysfunction, more tricuspid valve annular dilation and
tethering, and worsening TR. Eventually, the RV fails,
causing increased RV diastolic pressure and a shift of the
interventricular septum toward the LV. Because of
ventricular interdependence, this might compress the LV,
causing restricted LV filling and increased LV diastolic
and pulmonary artery pressure.19 Increased left atrial size
and pressure might also cause atrial fibrillation, which in
turn causes right atrial dilation leading to further tricuspid
annular dilation. Atrial fibrillation has been recognized as
an important risk factor for the development of TR in pa-
tients with mitral valve disease as well as for the persistence
or occurrence of TR after mitral valve surgery or balloon mi-
tral valvotomy.2 The majority of patients in the study were in
atrial fibrillation.diovascular Surgery c Volume 139, Number 6 1477
TABLE 3. Risk factors associated with increased likelihood of higher
postoperative TR grade
Factor Estimate ± SE P value
Overall
Higher grade of preoperative TR 0.46  0.062 <.0001
Female 0.71  0.12 <.0001
Mitral valve replacement 0.40  0.11 .0003
Early phase
Surgical management of TR
(compared with rigid ring)
Flexible ring alone 0.41  0.13 .02
Peri-Guard alone 0.011  0.35 >.9
De Vega alone 6.9  3.02 .02
Kay procedure alone 7.5  3.02 .03
Annulusþ leaflet 0.47  0.404 .2
Kayþ leaflet 6.7  3.04 .03
Larger annuloplasty ring size* 5.7  2.7 .03
Lower LVEFy 0.78  0.14 <.0001
African American 0.52  0.19 .005
History of heart failure 0.43  0.14 .002
Lower body surface areaz 1.4  0.78 .07
Late phase
Surgical management of TR
(compared with rigid ring)
Flexible ring alone 0.72  0.21 .0007
Peri-Guard alone 2.3  0.40 <.0001
De Vega alone 0.64  5.6 .9
Kay procedure alone 1.7  5.6 .8
Larger annuloplasty ring size* 1.7  4.9 .7
Lower GFRx 0.81  0.21 .0002
Preoperative permanent pacemaker 1.3  0.29 <.0001
At least one coronary artery
system diseased
0.97  0.22 <.0001
Larger LV mass indexk 0.38  0.087 <.0001
TR, Tricuspid regurgitation; SE, standard error; LVEF, left ventricular ejection frac-
tion; GFR, glomerular filtration rate; LV, left ventricle. *Log(annuloplasty ring
size), logarithmic transformation. yLog(LVEF), logarithmic transformation. z(1/
body surface area), inverse transformation. x(60/GFR), inverse transformation.
k(LV mass index/120)2, squared transformation.
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Annulus level. Tricuspid annular dilatation has long been
recognized as a constant feature of secondary TR20 and thus
has been the primary target for intervention. Different surgical
methods to treat or prevent secondary TR have been used at the
annulus level: prosthetic ring annuloplasty introduced by Car-
pentier and colleagues21 and suture annuloplasty introduced
by De Vega and colleagues.4 Recent long-term studies suggest
that ring annuloplasty is more durable than suture annulo-
plasty. Data from the surgical literature suggest that more
than 85% of patients having a ring annuloplasty will be free
from 2þor greater TR 10 years after surgery.3,14
A number of series have reported high recurrence of TR after
the De Vega technique, particularly in patients with severe tri-
cuspid annular dilation or pulmonary hypertension.3,22
A randomized study of 159 patients comparing Carpentier
ring annuloplasty with De Vega suture annuloplasty demon-1478 The Journal of Thoracic and Cardiovascular Surstrated a higher recurrence of 2þ or greater TR in the De
Vega group at 45-month follow-up (Carpentier 4 of 40, De
Vega 14 of 41; P<.001).22 Recently, 3-dimensional ring an-
nuloplasty has been introduced to address deformation of the
tricuspid annulus.23
Commissural level. Suture bicuspidization was originally
described by Kay, Maselli-Campagna, and Tsuji5 in 1965.
Ghanta and colleagues24 demonstrated that bicuspidization
(commissuroplasty) and ring annuloplasty were equally ef-
fective and durable at reducing TR up to 3 years postopera-
tively. Severe TR occurred in 8% of patients early after
annuloplasty. At midterm, 69% of patients with ring annu-
loplasty and 75% of those with bicuspidization commissur-
oplasty remained free of moderate or greater TR.
Leaflet level. Fukuda and colleagues25 suggested that an-
nuloplasty alone may reduce leaflet tethering to a level,
but might not suffice for severe leaflet tethering. Thus, on
the basis of these insights, we began to perform edge-to-
edge leaflet suture combined with prosthetic ring annulo-
plasty.6,7 Our results demonstrate that inclusion of this
leaflet-level technique does not provide additional benefit
to rigid ring annuloplasty alone.
Why Is Permanent Elimination of Secondary TR
Difficult?
Our study demonstrates that current approaches to ad-
dressing secondary TR at annular, commissural, and leaflet
levels are insufficient to eliminate TR. We speculate that
this may be due to imperfect annuloplasty or failure to ad-
dress other anatomic considerations and levels contributing
to its pathophysiology. The normal tricuspid annulus is
saddle-shaped, with its highest points in anteroposterior ori-
entation and lowest points in mediolateral orientation. In
secondary TR, the annulus becomes dilated, flattened, and
circular.17,18 Fukuda and colleagues25 additionally demon-
strated an asymmetric reduction in tricuspid annular contrac-
tion in patients with secondary TR. This may be important if
it is a critical pathophysiologic factor in secondary TR devel-
opment, in which case the presence of annular dilatation pre-
disposes a patient to future TR. Interestingly, in patients with
chronic pulmonary thromboembolic hypertension in whom
TR resolved after pulmonary thromboendarterectomy and
in patients who had successful mitral balloon valvotomy,
there was no change in tricuspid annular dilatation after res-
olution of pulmonary hypertension. This implies that tricus-
pid annular dilatation might be irreversible, which may be
the cause of late TR in mitral valve disease. Secondary
remodeling of the RV leads to conformational change of
the trabecular septomarginalis, resulting in displacement of
the free wall and outflow tract of the RV and the entire sub-
valvular apparatus, predominantly of the anterior leaflet.
These levels—chordae, papillary muscle, and RV wall—
are unaddressed by any current surgical technique that tar-
gets only annular, commissural, or leaflet levels.gery c June 2010
FIGURE 4. Freedom from reoperation (Kaplan–Meier estimates) according to tricuspid valve (TV) procedure. Vertical bars represent 68% confidence limits
(equivalent to 1 standard error).
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in the edge-to-edge group could be related to the fact that
these patients had an incision over the dome of the left
atrium to approach the mitral valve. As described by Guirau-
don, Ofiesh, and Kaushik,26 this sacrifices the sinoatrial
node artery in 100% of patients and increases the occurrence
of early transient nodal rhythm. Kumar and colleagues27
noted that transient junctional rhythm and conduction abnor-
malities were common early postoperatively.
Limitations
This is an observational clinical cohort study in which dif-
ferent surgical techniques were used to address secondary
TR, introduced at different times, in part because of dissatis-FIGURE 5. Survival after tricuspid valve repair accordi
The Journal of Thoracic and Carfaction with effectiveness, and surgeon preference. As in all
previous studies, detailed analyses of RV morphology and
function were lacking. Postoperative assessment of TR relied
on opportunistic TTEs, which could lead to ascertainment
bias and overestimation of prevalence of higher TR grades.
CONCLUSIONS
Rigid prosthetic ring annuloplasty, standard or 3-dimen-
sional, provides early and sustained reduction of TR second-
ary to left-sided valve disease without need for an additional
leaflet procedure. However, results are imperfect, possibly
because other anatomic levels (subvalvular, papillary
muscle, and RV) contributing to its pathophysiology are
unaddressed.ng to procedure performed. Format is as in Figure 4.
diovascular Surgery c Volume 139, Number 6 1479
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1995;60:426-30.APPENDIX 1: Variables Used in Analyses
Preoperative Variables
Demographic:Age (years), gender, race, weight (kg), height
(cm), body surface area (m2), body mass index (kg $ m2), race
Symptoms: NYHA functional class (I–IV), emergency
operation
LV function/structure: Degree of LV dysfunction
(1¼ none, 2¼mild, 3¼moderate, 4¼ severe), ejection frac-
tion (%), previous myocardial infarction, inner diameter in
diastole (cm), inner diameter in systole (cm), diastolic volume
(mL), systolic volume (mL), diastolic volume index (mL $
m2), systolic volume index (mL $ m2), fractional shortening,
relative wall thickness (wall stress), mass (g), mass index
(g $ m2), posterior wall thickness (cm), septal thickness (cm)
Left atrial structure: Diameter (cm), volume (mL), vol-
ume index (mL $ m2)
Valve pathology: Aortic valve regurgitation, aortic valve
stenosis, mitral valve regurgitation, mitral valve stenosis,
pulmonary valve regurgitation
Coronary anatomy: Left main trunk disease (% stenosis),
left anterior descending coronary artery system disease(maximum% stenosis), right coronary artery system disease
(maximum % stenosis), left circumflex coronary artery
system disease (maximum% stenosis)
RV function: TR, RV systolic pressure (mm Hg)
Other cardiac comorbidity: Atrial fibrillation, hyperten-
sion, history of cardiac disease, complete heart block/pacer,
preoperative permanent pacemaker, ventricular arrhythmia,
endocarditis
Noncardiac comorbidity: Treated diabetes, insulin-treated
diabetes, history of peripheral arterial disease, history of smok-
ing, carotid disease, popliteal disease, creatinine (mg $ dL1),
blood urea nitrogen (mg $ dL1), bilirubin (mg $ dL1), creat-
inine clearance, glomerular filtration rate, hematocrit (%)
Experience: Date of operation (years since January 1,
1990)
Procedure: Tricuspid valve (rigid ring [Carpentier–Ed-
wards, McCarthy–Carpentier, IMR ETlogix; Edwards Life-
sciences, Irvine, Calif], flexible ring [Cosgrove–Edwards,
TAB Tailor; St Jude Medical, Inc, St Paul, Minn], Peri-
Guard, De Vega, Kay, edge-to-edge [double or triple leaflet
with annuloplasty or Kay]), mitral valve repair/replacement,gery c June 2010
Navia et al Acquired Cardiovascular Diseaseaortic valve repair/replacement, coronary artery bypass
grafting, surgical ablation for atrial fibrillationA
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DDiscussion
Dr Farzan Filsoufi (New York, NY). I have a disclosure; I am
a speaker for Edwards Lifesciences. First, I congratulate you, Dr
Navia, for this important study, which includes a large cohort of pa-
tients. I would also like to remind our audience that the first part of
this study, from 1990 to 1999, which included 800 patients, was
presented by Dr McCarthy at the Eighty-third Annual Meeting of
The American Association for Thoracic Surgery and published in
this Journal in March 2004.
I think the main conclusions of your work, with which I agree, is
that the remodeling annuloplasty with either a Carpentier & Edwards
semirigid ring or an MC3 ring (Edwards Lifesciences) is superior to
other techniques such as suture annuloplasty and flexible band annu-
loplasty, and, as Dr Tirone David has shown, it has been associated
with an improved long-term survival. I think the second important
conclusion is that the palliative techniques, such as edge-to-edge re-
pair technique, do not play any role in further improving outcome
after a remodeling annuloplasty. Finally, although remodeling annu-
loplasty is superior to other techniques, it is associated with an early
failure rate of about 10% to 15% in your study. This has not been our
experience at Mount Sinai Medical Center. Therefore, most of my
discussion will be directed to our understanding the mechanism of
this early failure.
First, as you know, most patients with functional TR have iso-
lated annular dilatation, type I dysfunction, or restricted leaflet mo-
tion, type IIIb dysfunction, with associated annular dilatation.
Have you observed any difference of outcome, particularly with
respect to early or late failure, between these 2 groups of patients,
and have you been able to identify any risk factors such as RV dys-
function, enlargement, or pulmonary hypertension for this early
failure?
Dr Navia. Thank you for your comments. We have not found
any distinctions about this pathologic study in terms of regurgita-
tion. In terms of the treatment, I agree with you; I think the best be-
haved ring is the rigid ring, and then also the 3-dimensional rings
behaved the same. We have not observed any differences of early
or late TR between these 2 groups.
Dr Filsoufi. My second question is regarding the ring sizing.
What criteria do you use for ring sizing and do you make any dif-
ference in patients with type A versus type IIIb, particularly with
regard to undersizing?
Dr Navia. That is a good question. We do not make any different
criteria for sizing between type A and type IIIb of the Carpentier clas-
sification. We usually undersize the ring. We usually size by the sur-
face area of the septal leaflet and, based on that, we place the ring; the
choice of the specific ring depends on the surgeon preference.
Dr Filsoufi. In the article published in 2004 by Patrick McCar-
thy, which reported your cohort again from 1990 to 1999, the ma-
jority of patients who underwent a semirigid annuloplasty had
a size 32 mm or 34 mm, and they were not undersized. In the dis-
cussion of this same manuscript, Dr McCarthy mentioned that
undersizing was commonly performed, at least in patients with car-
diomyopathy, during the second part of your study period. Do youThe Journal of Thoracic and Carhave any data comparing patients who have a 2-size remodeling an-
nuloplasty versus an undersized remodeling annuloplasty?
Dr Navia. No, we do not have any data for that.
Dr Filsoufi. My fourth question is this: To prevent the recur-
rence of early TR, do you use any adjunctive procedures such as
anterior leaflet patch extension, as suggested by Gilles Dreyfus?
DrNavia. This is a very important issue. We do not use any kind
of leaflet extension with bovine or autologous pericardium, but I
think we need to start thinking about new procedures. I do not think
the ring itself is completely effective in reducing TR completely.
The other component that we miss here is the ventricle, and we
need to start thinking of the subvalvular apparatus and the ventricle
geometry and which role they play on secondary TR in this popu-
lation. I think with just the ring itself, TR can be reduced but not
completely eliminated.
Dr Filsoufi. My final question is this: In the presence of recur-
rent 3þ to 4þTR early after the operation, how do you use this in-
formation? What is the percentage of patients who had reoperations
and what type of procedure do you perform?
Dr Navia. This is a very good question. The rate of 3þ to 4þTR
before discharge is very low, but when it happens, I think these pa-
tients need to return to the operating room. If the valve cannot be
repaired again, it must be replaced. We usually use a tissue valve.
I think it is safer to replace the valve than to send the patient
home with the risk that he or she will return with full right heart fail-
ure. Many of these patients (eg, 48% of our patients) require a reop-
eration, and this will be the third one; they have a very high risk of
morbidity and mortality—between 30% and 40%. Therefore, I think
if you have patients with 3þ to 4þTR before discharge, you have to
return them to the operating room before sending them home.
Dr Norberto De Vega (Malaga, Spain). I congratulate the au-
thors for such a good study. I have some comments and questions
for Dr Navia.
Nowadays, we do not have any problem with how to treat the tri-
cuspid valve. We always use a properly performed suture annulo-
plasty, but we think that it is completely different if it is
a rheumatic or a degenerative disease. In patients with rheumatic
disease, we do not think there is such a clear-cut difference as we
thought in the past among organic and functional regurgitation.
For the past 15 years, we have visually explored every tricuspid
valve of our patients with rheumatic mitral disease, and in most of
them, even in those without regurgitation at that time, we found
some subtle changes in the leaflets that probably progress with
the passing of time and are responsible for the TR that appears
late after left heart valve surgery. To avoid that, we have proposed
to fix the tricuspid annulus in every case to break the vicious circle
triggered by any degree of TR and in which annular dilatation plays
an essential role.
Do you agree that there is no clear-cut difference, in patients
with rheumatic disease, between functional and organic tricuspid
disease?
Second, when those patients come back late after mitral surgery
with isolated TR, do you have any clue to differentiate patients who
are going to benefit by an operation from the ones who will not?
Dr Navia. Thank you for the question, Dr De Vega. These cer-
tainly are 2 different patient groups. However, we analyzed your
technique in these 2 populations, rheumatic and degenerative.
We have more patients with degenerative than rheumatic disease,diovascular Surgery c Volume 139, Number 6 1481
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24% of the patients have a recurrent 3þ to 4þTR at 5 years with
the De Vega technique.
Dr Tirone E. David (Toronto, Ontario, Canada). I enjoyed
your paper very much. Years ago, your cardiologists published
the importance of tethering of the tricuspid leaflets on the outcome
of tricuspid annuloplasty. They have been telling us that surgeons
are overlooking tethering of the anterior and posterior leaflets,
which is not mentioned in your study at all. Aren’t you talking to
your cardiologists? Why didn’t you address this issue when you
did an annuloplasty? I am saying that because I learned this from
your cardiologists, and since we introduced this concept in my op-
erating room, we have not had recurrent TR anymore if you look at
tethering before you do annuloplasty.
Dr Navia. That is a very good point. We have not taken a look
completely at the tethering effect in all the cases, so we do not
have a complete echocardiography result to give the data. Lately,
we are starting to get more perspective to see this distance of the teth-
ering and the unbalanced coaptation of the leaflets to be more proac-
tive and try to use new remodeling shaped rings. But I cannot give in
this presentation the real number of echocardiograms because we do
not have it. Usually, the echo we have mainly is grade of TR. It is
very difficult to quantify the leaflet moving and the leaflet coaptation.
Dr David. Are you asking the sonographer before the operation
what segment has tethering before you do an annuloplasty?
Dr Navia. Yes, we started doing more and more right after the
Yacoub paper, and our papers also showed that the deepness of
the coaptation owing to the tethering of the tricuspid leaflet creates
more recurrence of TR over time. That is a very important issue.
Otherwise, we are looking right now at different concentric changes
of the geometry of the RV, mainly the trabecular septomarginalis,
that pulls the RV free wall, changes the anterior papillary muscle,
and creates anterior leaflet tethering. We are now trying to
find new techniques, because we know that the ring alone is insuf-
ficient to completely eliminate the TR secondary to left-sided valve.
Without question, I cannot agree more with you; we are looking for
that.
Dr Richard J. Shemin (Los Angeles, Calif). One of the powers
of this study is the large number of patients. However, every sur-1482 The Journal of Thoracic and Cardiovascular Surgeon has in his or her armamentarium a whole variety of techniques,
and therefore there is bias. Very often you can do a propensity score
to try to level the field to be sure that the decision–making of the in-
dividual surgeon who has all these techniques at his or her disposal
is kind of eliminated. Did you think of doing that?
Dr Navia. That is a reasonable question. That could be the best
way to analyze this study. However, unfortunately it is a long pro-
cedure of 18 years with different surgeon preferences, so we did
only an observational cohort study. The next step would be to di-
rectly focus on propensity score analysis.
Dr Patrick M. McCarthy (Chicago, Ill). By way of disclosure,
I am the inventor of the Edwards MC3 ring.
Dr Navia, it appeared that about 15% of the patients had a perma-
nent pacemaker before surgery. In the study that we had reported
before, that was one of the major risk factors for failure. How do
you manage that in this series? Is there a standardized approach
now for how to deal with permanent pacing wires?
Dr Navia. Thank you, Dr McCarthy. We found the same situa-
tion—15% of the patients had a previous pacemaker. This is one of
the high risk factors of recurrent TR, because the pacemaker leads
can erode or perforate the leaflet and sometimes become stuck to
the leaflet, impeding free leaflet movement and creating TR. We
manage this by removing the wires through the tricuspid valve
and then placing permanent epicardial leads on the RV. I think
that is the best way to eliminate the potential problems of recur-
rence of TR or cause a negative effect on the tricuspid valve repair
technique.
Dr David H. Adams (New York, NY). Dr Navia, can I ask you to
speculate on the mechanism of failure with the flexible ring? In the
mitral position, we know the intertrigonal distance dilates in heart
failure and dilated cardiomyopathy, but I am not aware of any ev-
idence that the septum of the tricuspid annulus dilates in cardiomy-
opathy. Do you have any idea, any mechanism why you are seeing
recurrence of TR with flexible bands?
Dr Navia. I really do not know the intrinsic mechanism of fail-
ure of the flexible bands. Perhaps the flexible ring does not have
enough strength to maintain the new annular size and does not pre-
vent annular dilation as well as the rigid ring when the RV con-
tinues to remodel over time. That could be one of the reasons.gery c June 2010
APPENDIX E1. Number of patients with echocardiograms available at and beyond various time points, and number of echocardiograms available for anal-
ysis. Black bars ¼ patients; gray bars ¼ echocardiograms.
APPENDIX E2: Method of Analysis for Other
Outcomes
In-hospital morbidity and mortality are presumed unad-
justed according to surgical management of TR as frequen-
cies and percentages. Tricuspid valve reoperation, all-cause
mortality, and requirement for a permanent pacemaker were
assessed nonparametrically using the Kaplan–Meier method
and parametrically by hazard function decomposition.E1
(For additional details, see http://www.clevelandclinic.org/
heartcenter/hazard.)
RV systolic pressure was estimated using the method of
Berger and colleagues.E2 A total of 3154 TTEs were
available for 1512 patients (66% of the study group). Tem-
poral trend was estimated by nonlinear mixed modeling and
temporal decomposition as described under Methods in the
main article.
Temporal trend of NYHA functional status was estimated
from 1331 follow-up records available for 751 (33% of
study group) patients. Because of low frequency, NYHA
classes III and IV were collapsed into a single category for
ordinal logistic regression analysis using nonlinear mixed
modeling and temporal decomposition.
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APPENDIX E3. In-hospital morbidity and mortality
Flexible ring
(n ¼ 1052)
Rigid ring
(n ¼ 584)
Peri-Guard
(n ¼ 185)
De Vega
(n ¼ 129)
Kay
(n ¼ 248)
Annulusþ leaflet
(n ¼ 35)
Kayþ leaflet
(n ¼ 38)
P valueNo. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Morbidity
Intraop/postop IABP 49 (4.7) 25 (4.3) 7 (3.8) 8 (6.2) 2 (0.81) 3 (8.6) 1 (2.6) .09
Return to OR for bleeding 69 (6.6) 54 (9.2) 19 (10) 14 (11) 11 (4.4) 2 (5.7) 3 (7.9) .08
Stroke 30 (2.9) 12 (2.1) 1 (0.54) 4 (3.1) 8 (3.2) 1 (2.9) 1 (2.6) .6
Myocardial infarction 6 (0.57) 5 (0.86) 1 (0.54) 1 (0.78) 0 (0) 0 (0) 0 (0) .8
Renal failure 54 (5.1) 31 (5.3) 9 (4.9) 13 (10) 18 (7.3) 4 (11) 2 (5.3) .2
Respiratory insufficiency 143 (14) 95 (16) 39 (21) 31 (24) 33 (13) 9 (26) 6 (16) .006
Septicemia/sepsis 61 (5.8) 39 (6.7) 7 (3.8) 20 (16) 17 (6.9) 4 (11) 1 (2.6) .001
In-hospital death 52 (4.9) 34 (5.8) 16 (8.6) 18 (14) 12 (4.8) 3 (8.6) 12 (5.3) .003
Intraop/postop, intraoperative or postoperative, IABP, intraoperative aortic balloon pumping; OR, operating room.
APPENDIX E4. Freedom from reoperation related to tricuspid valve. Each symbol represents a reoperation, vertical bars are 68% confidence limits (equiv-
alent to 1 standard error), and solid line enclosed within dashed 68% confidence limits is parametric estimate.
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APPENDIX E5. Overall survival after tricuspid valve repair. Format is as in Appendix E4
APPENDIX E6. Freedom from permanent pacemakers (PPM) after tricuspid valve repair according to procedure performed. Format is as in Figure 4.
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APPENDIX E7. Temporal trend of postoperative right ventricular systolic pressure (RVSP) according to procedure group. Format is as in Figure 2.
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APPENDIX E8. Temporal trend of postoperative New York Heart Association (NYHA) functional class according to procedure performed. Format is as in
Figure 2. A, NYHA class I. B, NYHA class III/IV.
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